BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19288012)

  • 1. Enhanced effects of PPARgamma ligands and RXR selective retinoids in combination to inhibit migration and invasiveness in cancer cells.
    Papi A; Rocchi P; Ferreri AM; Guerra F; Orlandi M
    Oncol Rep; 2009 Apr; 21(4):1083-9. PubMed ID: 19288012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RXRgamma and PPARgamma ligands in combination to inhibit proliferation and invasiveness in colon cancer cells.
    Papi A; Rocchi P; Ferreri AM; Orlandi M
    Cancer Lett; 2010 Nov; 297(1):65-74. PubMed ID: 20510503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of retinoic acid and IIF on growth, migration and invasiveness in the U87MG human glioblastoma cell line.
    Papi A; Bartolini G; Ammar K; Guerra F; Ferreri AM; Rocchi P; Orlandi M
    Oncol Rep; 2007 Oct; 18(4):1015-21. PubMed ID: 17786368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined low doses of PPARgamma and RXR ligands trigger an intrinsic apoptotic pathway in human breast cancer cells.
    Bonofiglio D; Cione E; Qi H; Pingitore A; Perri M; Catalano S; Vizza D; Panno ML; Genchi G; Fuqua SA; Andò S
    Am J Pathol; 2009 Sep; 175(3):1270-80. PubMed ID: 19644018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of ERK activity enhances the cytotoxic effect of peroxisome proliferator-activated receptor γ (PPARγ) agonists in HeLa cells.
    Chang HK; Kim DS; Chae JJ; Kim M; Myong JP; Lee KH; Lee MW; Park TC
    Biochem Biophys Res Commun; 2017 Jan; 482(4):843-848. PubMed ID: 27888104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoid X receptor and peroxisome proliferator-activated receptor-gamma agonists cooperate to inhibit matrix metalloproteinase gene expression.
    Burrage PS; Schmucker AC; Ren Y; Sporn MB; Brinckerhoff CE
    Arthritis Res Ther; 2008; 10(6):R139. PubMed ID: 19046432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPARgamma and RXRgamma ligands act synergistically as potent antineoplastic agents in vitro and in vivo glioma models.
    Papi A; Tatenhorst L; Terwel D; Hermes M; Kummer MP; Orlandi M; Heneka MT
    J Neurochem; 2009 Jun; 109(6):1779-90. PubMed ID: 19457135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell death is induced by ciglitazone, a peroxisome proliferator-activated receptor γ (PPARγ) agonist, independently of PPARγ in human glioma cells.
    Lee MW; Kim DS; Kim HR; Kim HJ; Yang JM; Ryu S; Noh YH; Lee SH; Son MH; Jung HL; Yoo KH; Koo HH; Sung KW
    Biochem Biophys Res Commun; 2012 Jan; 417(1):552-7. PubMed ID: 22177955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands.
    Crowe DL; Chandraratna RA
    Breast Cancer Res; 2004; 6(5):R546-55. PubMed ID: 15318936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific thiazolidinediones inhibit ovarian cancer cell line proliferation and cause cell cycle arrest in a PPARγ independent manner.
    Al-Alem L; Southard RC; Kilgore MW; Curry TE
    PLoS One; 2011 Jan; 6(1):e16179. PubMed ID: 21283708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effects of RXR alpha and PPAR gamma ligands to inhibit growth in human colon cancer cells--phosphorylated RXR alpha is a critical target for colon cancer management.
    Yamazaki K; Shimizu M; Okuno M; Matsushima-Nishiwaki R; Kanemura N; Araki H; Tsurumi H; Kojima S; Weinstein IB; Moriwaki H
    Gut; 2007 Nov; 56(11):1557-63. PubMed ID: 17604322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-invasive effects and proapoptotic activity induction by the rexinoid IIF and valproic acid in combination on colon cancer cell lines.
    Papi A; Ferreri AM; Guerra F; Orlandi M
    Anticancer Res; 2012 Jul; 32(7):2855-62. PubMed ID: 22753748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPARγ and RXR ligands disrupt the inflammatory cross-talk in the hypoxic breast cancer stem cells niche.
    Papi A; De Carolis S; Bertoni S; Storci G; Sceberras V; Santini D; Ceccarelli C; Taffurelli M; Orlandi M; Bonafé M
    J Cell Physiol; 2014 Nov; 229(11):1595-606. PubMed ID: 24604522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pro-apoptotic effect of ciglitazone in leukemic HL-60 cells via PPARγ and P38 MAPK signaling pathway].
    Liu JJ; Liu WD; Liu XD; Raj-Shrestha P; Liu PQ; Huang HQ; Wu CB; Wang CZ; Xu Y; Xiao RZ; Lin DJ; Huang RW
    Zhonghua Yi Xue Za Zhi; 2010 Aug; 90(32):2270-4. PubMed ID: 21029675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells.
    Hashimoto K; Ethridge RT; Evers BM
    Int J Gastrointest Cancer; 2002; 32(1):7-22. PubMed ID: 12630765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGFR inhibition by (-)-epigallocatechin-3-gallate and IIF treatments reduces breast cancer cell invasion.
    Farabegoli F; Govoni M; Spisni E; Papi A
    Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28465354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor-γ inhibits pancreatic cancer cell invasion and metastasis via regulating MMP-2 expression through PTEN.
    Li Y; Zhang DW; Lin DQ; Cao LQ
    Mol Med Rep; 2015 Oct; 12(4):6255-60. PubMed ID: 26299428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of peroxisome proliferator-activated receptor-gamma induces apoptosis on acute promyelocytic leukemia cells via downregulation of XIAP.
    Liu JJ; Guo YW; Fang ZG; Si XN; Wu XY; Liu PQ; Lin DJ; Xiao RZ; Xu Y; Wang CZ; Li XD; He Y; Huang RW
    Int J Mol Med; 2009 Nov; 24(5):623-32. PubMed ID: 19787196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinational effect of PPARγ agonist and RXR agonist on the growth of SGC7901 gastric carcinoma cells in vitro.
    Liu Y; Zhu ZA; Zhang SN; Mou J; Liu L; Cui T; Pei DS
    Tumour Biol; 2013 Aug; 34(4):2409-18. PubMed ID: 23605322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand Activity of Group 15 Compounds Possessing Triphenyl Substituent for the RXR and PPARγ Nuclear Receptors.
    Hiromori Y; Ido A; Aoki A; Kimura T; Nagase H; Nakanishi T
    Biol Pharm Bull; 2016; 39(10):1596-1603. PubMed ID: 27725436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.